Skip to content
DataLookout
Menu

LaLeLaNCT07631377

The LalelaLung Study: Digital Stethoscope Clinical Evaluation

StatusNot Yet Recruiting
PhasePhase 4
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Start date pushed from Nov 2, 2026 to Dec 7, 2026
  2. Notable Start date: Aug 17, 2026 to Nov 2, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 6 of 12 entries
    • Publications: details revised at 30 of 34 entries
    • Study description shortened, about 3 words
  3. Minor Start date: Jul 20, 2026 to Aug 17, 2026v3
  4. Minor Secondary endpoints: details revised at 1 of 12 entriesv2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Proportion of children correctly classified with Pneumonia (Diagnostic accuracy of pneumonia diagnosis - IMCI enhanced by AI-enabled digital stethoscope vs. standard IMCI)
Timeframe: Index clinic visit (Day 1); 7-day follow-up

Secondary (12)

Accuracy, sensitivity, specificity, and positive/negative predictive values (Diagnostic accuracy relative to routine health care worker (HCW) diagnosis)
Proportion of correctly indicated antibiotic decisions (Accuracy of antibiotic decision-making)
Accuracy of pneumonia diagnosis (Expanded lung-sound classification accuracy)
Agreement between AI lung-sound classification and physician auscultation
Proportion of digital recordings successfully obtained and interpretable (Feasibility of digital auscultation)
Show 7 moreShow less
Mean time to obtain standardied chest-position recordings (operational metrics of digital auscultation)
Caregiver-reported chld status
Proportion of routine HCW encounters (HCW fidelity to the IMCI algorithm)
Proportion of interpretable lung-sound recordings (Recording quality - AI Diagnostics digital stethoscope vs. StethoMe (non-inferiority)
Sensitivity, specificity, positive and negative predictive values (Diagnostic accuracy of AI-enabled digital stethoscope for pulmonary tuberculosis)
Agreement of automated respiratory-rate measurement and breath counts
Proportion of Perin Health Patch lung-sound recordings meeting pre-defined acousic quality criteria (Interpretability of Perin Health Patch lung-sound recordings)

Arms and interventions

AI-enhanced IMCIExperimental

Participants randomized to this arm undergo Integrated Management of Childhood Illness (IMCI) assessment enhanced by the StethoMe AI-enabled digital stethoscope. After the routine health worker IMCI evaluation, a study clinician performs a structured IMCI-based respiratory assessment and obtains digital lung-sound recordings at four standardized chest positions with the StethoMe device. The embedded algorithm computes respiratory rate and classifies abnormal lung sounds (crackles, wheezes) in real time. AI outputs remain concealed from health workers, study staff, and caregivers and do not influence clinical management. The intervention is the StethoMe AI-enabled digital stethoscope, which is applied during a single clinic encounter.

Standard IMCIActive comparator

Participants randomized to this arm receive standard IMCI assessment per WHO guidelines, in which pneumonia is classified using respiratory rate and chest indrawing without AI-enabled digital auscultation. Routine clinic health workers perform the IMCI evaluation and make all management decisions, including antibiotic prescription or referral. The intervention is the standard IMCI assessment, which is delivered during a single clinic encounter.

Devices: StethoMe AI-enabled digital stethoscope system

Diagnostic tests: Standard IMCI assessment